Deal Watch: Allergan Diversifies With Deals For Migraine Therapies, Ophthalmologic Device
Executive Summary
AMAG adds to its commercial and technological capabilities with a buyout of Cord Blood Registry. Meanwhile, ramifications of the GSK/Novartis asset swap from March continue, with GSK divesting a pair of vaccines to Pfizer, while Novartis acquires Australian biotech Spinifex.